We are refemng in this paper to traditional tests of genotoxicity that are essentially detecting properties correlated with the initiating activity of chemical and physical agents. In classical initiation-promotion experiments, promotion is changing dramatically tumor frequency, but a better correlation between initiation and tumor frequency may exist when carcinogenesis experiments in rodents utilize only an initiator agent. End points, metabolism and target organs ofshort term test may be not optimal in respect to the real initiation process. In conclusion, we have to expect a very high level of statistical noise in the correlation between short term tests and carcinogenicity in rodents. Correlations of this type are not unique in science. For instance, the input data for weather forecasting and the real weather are often related with a high level of statistical noise. But this is not considered a good reason for throwing away the quantitative component of the input information. Similarly, in this context the utilization of the quantitative component of the information improves in a moderate, but not negligible way the predictive value of the information offered from short term tests, especially when they are used in a battery. In this review we discuss the possibility that, when studying correlations between genotoxicity tests and carcinogenicity in rodents, a quantitative approach could replace with important advantages the qualitative approach generally adopted up to the present time. The qualitative approach appeared as a more modest but realistic approach to the complexities of these correlation studies. What we suggest is that a quantitative approach mathematically not less correct than the qualitative approach is feasible. More precise and useful information for risk assessment evaluations can be obtained.
INTRODUCTION
A great deal of infomation has been obtained about genotoxicity tests. It has been suggested that a nonrandom correlation exists between these tests and carcinogenicity in rodents. A simple reflection on processes that can induce an increased tumor frequency in rodents submitted to a given treatment, suggests that both initiation-type and promotiontype effects can achieve these results. Up to now, most tests of genotoxicity have essentially detected more initiators than promoters. As a consequence, results positive in carcinogenicity tests, but negative for a spectrum sufficiently large ofgenotoxicity tests should be discarded from correlation studies ofthe type discussed here.
Essentially, only a qualitative correlation between carcinogenicity in rodents and genotoxicity has been established. It has been found that, accepting as clear enough a discrimination between positive and negative results, the frequency of associated positives and associated negatives in Sets of genotoxicity and carcinogenicity data was apparently nonrandom (8). This quaIitative approach is obviously not taking into account the Significant differences in potency that chemical carcinogens can possess. Moreover, a CorollaW of the qualitative approach is that even information COnCernillg the quantitative level Of exposure to a given chemical is difficult to utilize. In other words, not only potency effects but also dose effects are ignored with the so-called qualitative approach. This situation is reminiscent of what hap-Pened in Pharmacology and other fields of toxicology a long time ago, when the homeopathic approach existed side by side with the quantitative (dosage and potency
Obviously, there is an explanation why the qual-itative approach has not been abandoned in this field of chemical carcinogenesis. The reason lies in the great complexities that the quantitative approach implies.
Our suggestion is that the number of problems in quantitative correlations is relatively large but discrete, and, above all, that not all of them have the same importance, and therefore even measurements and estimations, unmindful of some of the difficulties can already have significance. We could anticipate that a stepwise progress will gradually take place in the framework of the dosage and potency approach.
THE FIRST STEP IN THE QUANTITATIVE APPROACH. PREPARING A DATABASE OF
CARCINOGENIC POTENCIES The first step for establishing quantitative relationships between data obtained in genotoxicity tests and carcinogenicity in rodents is the preparation of a database of carcinogenic potencies.
In dealing with this problem we have encountered two major groups of difficulties. The first requirement was already recognized by us in 1982 (14) . We defined this problem as the setting of "boundary conditions" for acceptance (or refusal) and elaboration ofdata obtained from carcinogenicity studies. The problems are manyfold and are related both to the acquisition and computation of data. The second difficulty, and a crucial one was related to the question if our computations were arbitrary. In this case the ranks of potencies might change completely due to a change in the computation algorithm. However, if the philosophy that dictated the types of algorithm that might be used was such that the rank of potencies was relatively invariable, different sets of potencies calculated with different algorithms would remain strictly correlated.
An artisan database of carcinogenicity has been utilized by us for more than one hundred chemicals in previous studies of correlation between genotoxicity and carcinogenicity (1 1-22, 24-26) . We have now in preparation a final detailed database for about 113 chemicals (23) .
Recently Pet0 et a1 prepared an excellent database on potency of several chemical carcinogens (28, 30) . They examined about 3,000 long term chronic experiments relating. to 770 compounds. Their work deserves exceptional merit for the soundness of its approach. The TD,, (extrapolated dosage inducing tumors in 50% of the animals) used by the authors and the OPI (Oncogenic Potency Index) used by us are essentially the same parameter, except for a simple transformation algorithm.
In at least one significant respect the approach of Pet0 et al (28) is superior to ours: their computations are actuarially adjusted. Quoting directly from their words: ". . . if the material being tested is toxic, then premature death from non-neoplastic causes may prevent some dosed animals that would have developed tumors from actually doing so . . . ." This means that some compounds classified as uncertain according to our boundary conditions, after an actuarial adjustment of the data could have been shifted to positive. The first impression is that the real number of such cases is very small. For cases that we have already classified as positive, the actuarial correction will introduce almost negligible increases in the potency estimations, especially when compared with the span ofpotencies that is encompassed by the overall group of chemicals tested.
In the database work of Swirsky et a1 (30) and ours, 74 compounds are overlapped and only 39 compounds of our database are not represented in theirs. The extensive overlapping should allow an accurate assessment of the degree of concordance in the evaluation of potencies.
RELATIVE INVARIANCE OF POTENCY VALUES
As we anticipated, one of the problems with this database work could be that while accurate, the computation could be arbitrary to such an extent to make the work not very useful as reference point for quantitative correlation studies. We will attempt to prove that the first investigations about degrees of arbitrariness of these computations of carcinogenic potency suggest that arbitrariness is probably less than what would be suspected because these potencies are relatively invariant (each one in respect to the others) and perhaps to a higher degree than we could have expected.
The formula used for the computation of carcinogenic potency follows Meselson and Russell (9):
The above formula is based on the probability I for an animal of having at least one tumor, and if we assume for tumor appearance a Poisson distribution typical of a rare event, then I = 1e-"; where u is the average frequency of tumors per animal in the entire population. It will be u = -In( 1 -I), that would be expected to increase more linearly with dosage.
In conclusion, the numerator gives the tumor frequency per animal, obtained from incidence, through a simple transformation. At the denominator D has exponent 1, as if only a single step, in the multistep carcinogenesis process could be affected by chemicals.
Different carcinogens are almost always tested at subtoxic doses, and the range ofincidence measured 208 PARODI ET AL TOXICOLOGIC PATHOLOGY is relatively narrow. As a consequence, the problem of the exponent of D should not affect significantly comparisons amongst carcinogenic potencies. This problem should be kept in mind when extrapolations of effects are made at low doses. The presence in the denominator of the factor t, where t is not referred to the length of treatment (implicitly included in the parameter D), but to the duration of experiment, reflects the experience that in carcinogenesis there are "spontaneous" steps which have a possibility of occurring seemingly dependent on time. The exponent o f t is related to the possible number of steps of this type.
In order to investigate the relative invariance of the algorithm used for calculating carcinogenic potencies, we analyzed the relationship between sets of carcinogenic potencies obtained in independent experiments for the same compounds. We found that this type of internal correlation is acceptably high, about 0.8 for 56 compounds examined (18). The data utilized in this study were considered to have a bivariate lognormal distribution up to a sufficient extent. Similar results could be obtained even with a nonparametric approach. The carcinogenicity database to which we want to refer genotoxicity data seems to have a sufficient consistency in this respect.
A similar level of correlation (-0.8) was found for rat and mouse data, but in this case only 19 pairs of data were available. A higher level of internal correlation was found when variability related to variations in the OPI formula itself was examined. From our database at a partial stage of completion for about 100 different chemicals, correlations hicrher than 0.95 were mulations: OPI = found amongst the following for--In(l -I)
Log,,OPI values were used in all these correlation studies (24). In conclusion, the biological internal variability of the data is reasonable, and the algorithm-dependent variability seems minimal. Obviously other controls of this type, for instance for different administration routes, for acute and chronic treatments, will be useful. Similarly, not the tumor frequency per animal (u) but the ratio u,/u,(treated/ control) could be a more valuable parameter because a correction could be introduced for tumors more or less easily inducible. Whether this can be obtained on a systematic basis, or if at least it can be obtained by discarding the too easily induced tumors, remains to be verified. BOUNDARY CONDITIONS FOR TESTS OF GENOTOXICITY The database construction for a test of genotoxicity will pose some problems similar to the one already found for carcinogenic potencies (23) and some specific for a given genotoxicity test. ControIs of invariance and internal homogeneity will be required even for these data. At least for some genotoxicity tests, like SCEs measured in vim in bone marrow cells, the situation seems more simple than for carcinogenicity data (24). Again, the philosophy of the measurement of a potency is very simple, and the same as before, essentially an effect divided by a dosage.
GENERAL CONSIDERATIONS ON THESE CORRELATION STUDIES The major differences between genotoxicity tests and carcinogenicity studies can be perhaps summarized in this way. The genotoxicity tests reflect essentially irreversible alterations in the genome, like mutations and genomic rearrangements. These changes do not need to be related only to the initiation step in carcinogenesis, in the sense that more than one step could be of this type. However, promotional effects will go essentially undetected in genotoxicity tests (3, 27) . Some tests of cell transformation irt vitro could be a possible exception to this general statement, as with some type of promoter (1 0).
Even if our interest is limited to a prediction of carcinogenic potency for initiators-(non initiators should be relatively easy to identify as negative in the generality of genotoxicity tests)-the relatively high dosages of chemicals used in carcinogenicity studies can have a promotional effect in addition to their basic properties of DNA damaging and initiator agents (5) . The increment of tumors induced by this type of promotional effect is unpredictable on a general basis, and it will show up as added noise in correlation studies.
Other factors that can decrease the closeness of correlation can be related to problems of target organ, possibly different from the major tumor site, to problems of end point perhaps not too well correlated with a relevant and not repaired genomic damage (6) ; and generally inadequate metabolism, especially for irt vitro tests. Moreover, nonlinear kinetics in the dose-reponse relationship can be present also in carcinogenesis experiments. They could be dependent for instance on saturation of repair mechanisms (increased response), or saturation of metabolic activation mechanisms (decreased response) (7) .
We should expect that for all these reasons taken CARCINOGENICITY AND SHORT TERM TESTS  209 together, the correlation between genotoxicity tests and carcinogenicity will not be too high. In a certain' way it is, by far, more important to be able to measure the uncertainty of the estimation than to have a high correlation. It is perhaps worthwhile to note that when we want to measure the potency of an initiator (with extrapolations to lower, more "physiological" dosages), a discrepancy induced by the possible promotional effect of a high dosage of an initiator is a weakness of the carcinogenicity study and not of the genotoxicity test. The latter does not always need to be the culprit for relatively low correlation. In this case the prediction of carcinogenicity extrapolated from genotoxicity tests could be better than the prediction of a global correlation study.
OTHER CONSIDERATIONS FROhl A hlORE
MATHEhlATICAL SIDE OF VIEW In previous studies we worked essentially with a statistical parametric approach, assuming a sufficiently lognormal bivariate distribution of pairs of carcinogenicity and genotoxicity data (24) . We have not yet analyzed if the degree of normality is really sufficient for a parametric approach. Even with this limitation in mind, it seems important to underline what we have observed in a previous work (24) : the size of a confidence interval around a given predicted value does not only depend on the correlation level r, but also on the distribution of potencies in a set ofgenotoxicity and carcinogenicity values. This point evidenciates the thorny problem of defining the entire population of chemical carcinogens and of representativity of our sample set in respect to that ideal population. Only if the dispersion of the data in our sample is representative ofthe dispersion of the data in the entire population (and only to that extent), it will be possible to trust the confidence limits estimated with standard parametric statistical procedures (29) .
Another problem is that for rather large samples the confidence belts of a given estimation depend essentially only on the level of r and the dispersion ofthe data. However, ifthe samples are small, there will be a great uncertainty about the true value of r itself (29) . This point can become important in dealing with a test predictivity related to a small subset, referred to a specific chemical class.
QUANTITATIVE PREDICTIVITY OF CARCINOGENICITY FOR SEVERGL
GENOTOXICiTY TESTS A summary of the results that we have obtained in this field is reported in Fig. 1 . A demonstration that differences in correlation levels observed for different genotoxicity tests never reach statistical significance has already been formulated elsewhere CORIUflCl LLIfL YITn CARCIUI6INlCl~ 0 0.1 0.2 0.3 0,4 0.5 0.6 0.7 0.8 0.9 (24). Since the size of the samples in Fig. 1 is generally larger than sample sizes reported in the literature regarding more restricted families of chemical compounds, it seems evident that reports about a purported superiority of a given test above another, are probably unfounded. A possible exception are differences related to specific chemical classes. We have observed that several short term tests show a different predictivity for different classes of chemicals. Often, these differences have reached statistical significance, as reported in several previous studies (1 1, 16, 18, 24) . In some instances (1 1, 16, 24) the subsets were defined at the beginning of the study. In all cases no special effort was made to artificially build up a given subset. Perhaps the differences discussed above are real, even if the definition of a chemical class (as characterized by the presence of one or more functional groups) is to some extent arbitrary.
If we accept the idea that it is better to define the predictivity of a given genotoxicity test not in terms of a generic average, but with reference to specific chemical classes, then the problem of having to deal too often with too small subsets becomes very serious. It is difficult to enlarge these subsets, because the enlargement of an appropriate database of carcinogenicity will be a slow and costly process.
As previously reported (24) the one-tailed 95% confidence interval is approximately 300 times for the internal consistency of carcinogenic potencies. At the other extreme, the overall one-tailed dispersion ofcarcinogenic potencies is about 1 1,000 times. In between we have an one-tailed confidence interval of about 4,000 times for a genotoxicity test of average predictivity (r 2 0.4). It seems reasonable 210 PARODI ET AL TOXICOLOGIC PATHOLOGY to pose the question: can the above confidence limits be significantly reduced using a battery of tests?
IhlPROVED PREDIcrIVITY OF SHORT TERM TESTS With the qualitative approach, using a battery of short term tests we can only have a mixture of positive and negative results. It is difficult to decide between strategies that can increase disproportionately, according to the options, the number of false positive or the number of false negative results. However, Ashby et a1 reported that when the number of tests and the number of laboratories performing a given test is high, the frequency of positive reports tends to be proportional to the carcinogenic potency of the chemical studied. This related to a set of 10 chemicals investigated during the first IPCS study (1) . In this case the relatively large number of assays and laboratories in a way transforms a qualitative response into a graded response. We have discussed at length the increased predictivity offered by a battery of tests with the quantitative approach, in respect to a single test (14) . Both mathematics and common sense agree in suggesting that the tests of a battery should be complementary and not superimposable (i.e., different for metabolic activation, for end point, etc.). They should be at a sufficient extent correlated with carcinogenicity, but with a relatively poor internal correlation. Tests strictly correlated among themselves will be merely repetitive. We have calculated that for a battery of three tests a reduction of the one-tailed confidence limits from 4,000 times to 1,000 times is a realistic expectation (24). Perhaps a battery of five complementary tests could come close to the internal consistency of the carcinogenicity data, which has onetailed confidence limits of about 300 times.
OVERALL CONCLUSIONS What has been presented suggests that a quantitative approach can be applied to the use of short term tests. In many subsectors of this field a progressive refinement of the approaches seems possible, as it has happened with the quantitative approach in other fields of pharmacology and toxicology. Some difficulties will never be solved completely. For instance, the problem of representation of samples, both generally and for specific chemical classes.
Probably a database of carcinogenicity not arbitrary to a sufficient extent can be built, and the same can be true for a database concerning genotoxicity tests. Even recently some authors have implied that while it can be accepted that a qualitative relationship does exist between carcinogenicity and genotoxic activity, the existence of a quantitative rela-tionship remains doubtful (2). Previous work disproved this opinion (24). However, even from a mathematical point of view, such hypothesis is probably difficult to defend. In reality, the so-called qualitative correlation is just the limit of a rank correlation in which the ranks have been divided in only two subsets: compounds above and below the threshold of sensitivity of the detection method. From a mathematical viewpoint one would expect that if a clear rank correlation existed for a subdivision in two subsets, a similar degree of correlation would also remain for a subdivision in three or four subsets. In other terms, mathematically there is a continuum between the so-called qualitative approach and a quantitative approach. As a corollary, we would add the following: considering that carcinogenicity and genotoxicity are generally detected with different thresholds of sensitivity, the use of these dishomogeneous thresholds for a subdivision in two subsets is probably not the most appropriate. A more appropriate boundary for a subdivision of the data in two subsets, both for carcinogenicity and genotoxicity, could be a threshold Ievel of response that leaves 50% of the chemicals above and 50% below, in each of the two tests. At this point, the continuum existing between qualitative and quantitative approaches becomes even more evident: why not to investigate the correlation existing between compounds belonging to the first 25% of each of the two ranks?
We consider a rather original finding to have shown, perhaps not completely conclusively, but rather systematically (Fig. I) , that the predictivity of single genotoxicity tests is in principle significant but rather low, and, to have offered a first measurement of the degree of uncertainty of the estimation (14) . The measurement of this uncertainty is probably essential information if we want to contribute with genotoxicity studies to set safety levels for a given chemical. The predictivity can be clearly improved with the quantitative use of a battery of tests. The original elaboration in 1982 (24) is definitely susceptible of further improvements, but it remains probably as another important point.
For individual specific compounds ad lioc experimental work can suggest differences of various type in metabolism, and pharmacokinetics or other aspects between genotoxicity and carcinogenicity tests. There is no theoretical or practical obstacle in modulating the predicted potency according to these additional inputs. On the contrary, modulation will be easier starting with a number than with a yes or no response. Obviously, this work will be part of a more complex strategy that we will briefly mention below. In this article we were only interested in part of the 21 1 work, the "equivalences" in terms of carcinogenic potential o f an information ofgenotoxicity. A rather parallel situation probably exists for the relationship between carcinogenicity data in rodents and epidemiological data, for which some quantitative information on tumor frequency plus latency plus assumed dosage can be roughly established.
It has been already suggested that the number of these pairs of rodent-human data is probably rather small, including about or less than twenty pairs of different agents (2). We would anticipate even larger uncertainties for this level of relationship, but analogy with the present problem would suggest that a measurement of these large uncertainties should again be possible.
A t the end, the chain of measured uncertainties in the estimation should open the way to a more coherent set of threshold safety levels than what we have today. Obviously, the absolute values will remain partially arbitrary, because they will be linked to the degree of risk that we are prepared to accept.
